Synthesis Methodologies for Urea Derivatives in Medicinal Chemistry

Urea derivatives represent a cornerstone of medicinal chemistry, serving as versatile pharmacophores in enzyme inhibitors, receptor ligands and peptidomimetic frameworks. Traditional approaches have relied on phosgene or its derivatives to couple amines and carbamoyl chlorides, often under stringent conditions. Recent advances have shifted towards phosgene-free, metal-free and catalytic strategies that improve safety, sustainability and functional-group tolerance. Key methodologies include rearrangement protocols that convert protected amides into ureas, hypervalent iodine-mediated couplings of amines and amides, and the use of isocyanate surrogates to generate ureas in situ. These approaches operate under mild conditions, accommodate complex molecular architectures and facilitate late-stage modification of drug candidates. By integrating green chemistry principles with innovative activation modes, modern urea synthesis has expanded the accessible chemical space for drug discovery and enabled efficient scale-up for industrial applications.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Synthesis Methodologies for Urea Derivatives in Medicinal Chemistry publication trend

The graph below shows the total number of articles in synthesis methodologies for urea derivatives in medicinal chemistry across all publications each year (not limited to Nature Index journals).

Technical terms

Urea derivative: Organic compound bearing the –NH–CO–NH– functional group, widely used as a pharmacophore in drug design.

Lossen rearrangement: Reaction converting N-activated amides into isocyanates via intramolecular migration, facilitating urea formation upon nucleophilic attack.

Hypervalent iodine reagent: Oxidising agent in which iodine exhibits an oxidation state greater than +1, employed to mediate coupling reactions without metal catalysts.

Isocyanate surrogate: Precursor compound that generates isocyanate in situ, avoiding direct use of toxic isocyanate gases.

Late-stage functionalisation: Introduction or modification of functional groups in complex molecules at a late stage of synthesis, enhancing structural diversity.

Chemoselectivity: Selective reaction of one functional group in the presence of others, minimising by-product formation.

References

1. Deprotective Lossen rearrangement: a direct and general transformation of Nms-amides to unsymmetrical ureas. Chemical Science (2024).
2. Synthesis of Unsymmetrical Urea Derivatives via PhI(OAc)2 and Application in Late-Stage Drug Functionalization. Molecules (2024).
3. Benign synthesis of unsymmetrical arylurea derivatives using 3-substituted dioxazolones as isocyanate surrogates. Green Chemistry Letters and Reviews (2020).